Trial intelligence / Profile preview

CRD-102 for Right Heart Failure in LVAD Patients

NCT03217331Phase 2Completed

Sponsor
Cardiora Pty Ltd
Start
Mar 2018
Primary completion
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of milrinone in right-sided heart failure, sponsored by Cardiora Pty Ltd. Started Mar 2018; status: completed.

02

Drugs

milrinone
03

Conditions

right-sided heart failure

Beyond the preview

Go deeper on NCT03217331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03217331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call